BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23342874)

  • 1. [Lynch syndrome and microsatellite instability: a review].
    Desselle F; Verset G; Polus M; Louis E; Van Daele D
    Rev Med Liege; 2012 Dec; 67(12):638-43. PubMed ID: 23342874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microsatellite instability in the management of colorectal cancers.
    Buecher B; Cacheux W; Rouleau E; Dieumegard B; Mitry E; Lièvre A
    Dig Liver Dis; 2013 Jun; 45(6):441-9. PubMed ID: 23195666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability testing and its role in the management of colorectal cancer.
    Kawakami H; Zaanan A; Sinicrope FA
    Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.
    Imai K; Yamamoto H
    Carcinogenesis; 2008 Apr; 29(4):673-80. PubMed ID: 17942460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.
    Stadler ZK
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):29-41. PubMed ID: 25475571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and molecular consequences of microsatellite instability in human cancers].
    Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
    Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
    Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
    Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of microsatellite instability in colorectal cancer: A review.
    Gelsomino F; Barbolini M; Spallanzani A; Pugliese G; Cascinu S
    Cancer Treat Rev; 2016 Dec; 51():19-26. PubMed ID: 27838401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent discoveries in the molecular genetics of Lynch syndrome.
    Boland CR
    Fam Cancer; 2016 Jul; 15(3):395-403. PubMed ID: 27038793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.
    Battaglin F; Naseem M; Lenz HJ; Salem ME
    Clin Adv Hematol Oncol; 2018 Nov; 16(11):735-745. PubMed ID: 30543589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.
    Kloth M; Ruesseler V; Engel C; Koenig K; Peifer M; Mariotti E; Kuenstlinger H; Florin A; Rommerscheidt-Fuss U; Koitzsch U; Wodtke C; Ueckeroth F; Holzapfel S; Aretz S; Propping P; Loeffler M; Merkelbach-Bruse S; Odenthal M; Friedrichs N; Heukamp LC; Zander T; Buettner R
    Gut; 2016 Aug; 65(8):1296-305. PubMed ID: 26001389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microsatellite instability. A new predictive marker (?)].
    Dietmaier W
    Pathologe; 2010 Oct; 31 Suppl 2():268-73. PubMed ID: 20824433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer due to deficiency in DNA mismatch repair function: a review.
    Bellizzi AM; Frankel WL
    Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
    Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
    Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.
    Poulogiannis G; Frayling IM; Arends MJ
    Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynch or not Lynch? Is that always a question?
    Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
    Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between microsatellite instability and morphology in colorectal cancer].
    Szentirmay Z; Gallai M; Serester O; Szoke J; Tóth E
    Magy Onkol; 2010 Jun; 54(2):169-78. PubMed ID: 20576594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
    Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
    J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.